TABLE 3.

Preferences for 4-Month and 6-Month Injectable Contraceptive Method

BothKampalaLagos
Perceived benefits of 4-month injectable
  • Fewer facility visits

  • Offered option to self-inject

  • Shorter reinjection window (grace period)

Perceived benefits of 6-month injectable
  • Fewer facility visits

  • Administered by health worker

  • Intermediate duration

  • Long duration

Concerns about 4-month injectable
  • Side effects

  • Delayed return to fertility

  • Cost

  • Self-efficacy to self-inject

  • Stock-outs

  • Shorter reinjection window (grace period)

Concerns about 6-month injectable
  • Delayed return to fertility

  • Side effects

  • Cost

Target audience for 4-month injectable
  • Younger

  • Busy lifestyles

  • Limited access to facilities

  • Unmarried

  • Without children

  • Do not want long-acting reversible contraception

  • Frequent sexual activity

  • Married and unmarried

  • Wanting to space children

Target audience for 6-month injectable
  • Older

  • Married

  • Has children

  • In committed relationship

  • Frequent sexual activity

  • Taking other medications

  • Young, single mothers wanting to avoid frequent facility visits

Reasons for preferring 6-month injectable over 4-month injectable
  • Longer duration

  • Fewer facility visits

  • Easier to remember reinjection interval

  • Provider administered

  • Easier to differentiate

Reasons for preferring 4-month injectable over 6-month injectable
  • Intermediate duration

  • Broader appeal

Ideal duration of injectables
  • 6–12 months

Ideal number of injectable options
  • As many as needed to meet needs of users

  • 2 options (4- and 6-month) up to 12 options

  • 3 options (3-, 4-, and 6-month)